Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors
Assaf Moore, Shlomit Yust‐Katz, Oded Icht, Ruth Eliyahou, Noa Gordon, Aharon Yehonatan Cohen, Iris M. Goldstein, Nir Peled, T. Seigal, Alexandra Amiel, Elizabeth Dudnik
Topics & Concepts
BevacizumabMedicineRadiosurgeryDexamethasoneLung cancerClinical endpointRetrospective cohort studySurgeryRadiation therapyInternal medicineChemotherapyClinical trialBrain Metastases and TreatmentLung Cancer Research StudiesEffects of Radiation Exposure